Cafepharma | Pharmaceutical Sales, Medical Sales, Lab Sales

Cafepharma Today

March 27 2023 - Novartis' Kisqali cuts recurrence risk in early-stage breast cancer

Novartis' Kisqali cuts recurrence risk in early-stage breast cancer
Novo's high-dose Rybelsus win tees up regulatory filings
BioNTech's COVID-19 vaccine revenue forecasts lower than expected
BrainStorm secures FDA adcomm for ALS therapy NurOwn
*please scroll down for all the latest news*

Current News

submit a press release

Click here to stay updated on CP happenings

FDA adcomm votes in favor of Pfizer's Covid-19 pill Paxlovid

Endpoints

Thursday, March 16, 2023 - 6:18pm

tags:

FDA, Pfizer, Paxlovid, antivirals, COVID-19

Duchenne muscular dystrophy: major trials and events to watch in 2023

Clinical Trials Arena

Thursday, March 16, 2023 - 9:49am

tags:

DMD, Duchenne Muscular Dystrophy, clinical trials, gene therapy, FDA, Sarepta Therapeutics, SRP-9001, FibroGen, pamrevlumab, Capricor, CAP-1002, Santhera, ReveraGen, vamorolone

Royalty Pharma nabs $475M milestone from Pfizer upon migraine nasal spray OK

Endpoints

Thursday, March 16, 2023 - 9:46am

tags:

Pfizer, migraines, Royalty Pharma, Biohaven, zavegepant

Biogen gets EU court ruling in favor of blocking Tecfidera generic entry

Seeking Alpha

Thursday, March 16, 2023 - 9:44am

tags:

Biogen, EMA, Europe, MS, multiple sclerosis, Tecfidera, generics

FDA offers radio silence on question of spring Covid boosters, as other countries push ahead

Stat

Thursday, March 16, 2023 - 9:41am

tags:

FDA, boosters, vaccines, COVID-19

Bellicum Weighs Options After Serious Safety Concerns Halt Only Trials

BioSpace

Thursday, March 16, 2023 - 9:37am

tags:

Bellicum, clinical trials, GoCAR-T

Joint replacement business likely to be busy for the next year or more: BTIG analysts

Medtech Dive

Thursday, March 16, 2023 - 9:35am

tags:

Medtech, devices, joint replacements, Zimmer Biomet, Stryker

Medicxi backs siRNA-focused Aldena Therapeutics with $30M

Endpoints

Thursday, March 16, 2023 - 9:32am

tags:

Aldena Therapeutics, Medicxi, siRNA, dermatology

Novo Nordisk suspended from ABPI after code breach

Pharmaphorum

Thursday, March 16, 2023 - 9:30am

tags:

Novo Nordisk, ABPI

German biotech launches with ‘seamless’ gene editing platform built on evolving enzymes

Endpoints

Thursday, March 16, 2023 - 9:28am

tags:

Seamless Therapeutics, gene editing

Pfizer (PFE) Gets FDA Nod for Bivalent COVID Shot in Young Children

Yahoo/Zacks.com

Thursday, March 16, 2023 - 9:25am

tags:

Pfizer, BioNTech, FDA, pediatric, COVID-19, bivalent boosters, vaccines

Europe rues SVB loss as a cornerstone life science supporter

EP Vantage

Thursday, March 16, 2023 - 9:22am

tags:

SVB, biotech, life sciences, Europe

BioXcel takes surprising path with IPO of oncology spinout OnkosXcel

Fierce Biotech

Wednesday, March 15, 2023 - 9:37pm

tags:

BioXcel, IPOs, oncology, OnkosXcel

Into Africa – Is This the Future of Medtech?

Medical Devices and Diagnostics Industry

Wednesday, March 15, 2023 - 9:33pm

tags:

Africa, Medtech

Bristol Myers meets some diversity goals early, while missing others

Endpoints

Wednesday, March 15, 2023 - 9:28pm

tags:

Bristol Myers Squibb, diversity, clinical trials, clinical trial diversity

Johnson & Johnson shelves Carvykti's UK launch amid manufacturing shortfalls

Fierce Pharma

Wednesday, March 15, 2023 - 9:27pm

tags:

JNJ, Legend Biotech, CAR-T, Carvykti

Sigilon focuses on type 1 diabetes, reduces spend on MPS-1 after letting CMO go

Endpoints

Wednesday, March 15, 2023 - 9:24pm

tags:

Siglion Therapeutics, type 1 diabetes, cell therapy

Hookipa halts spending on cytomegalovirus vaccine after seeing phase 2 data

Fierce Biotech

Wednesday, March 15, 2023 - 9:21pm

tags:

Hookipa, CMV, vaccines, HB-101, kidney transplants

Bristol Myers blasts off with SpaceX to study biomanufacturing in space

Endpoints

Wednesday, March 15, 2023 - 9:18pm

tags:

Bristol Myers Squibb, SpaceX

Switch Therapeutics launches with $52M to capitalize on RNA medicine ‘era’

BioPharma Dive

Wednesday, March 15, 2023 - 12:11pm

tags:

Switch Therapeutics, RNA, funding

Pages

Latest CP Wire Articles

PharmaBlock Opens New R&D Facility in Pennsylvania ——Expanding Capacity to Deliver GMP Projects

Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy

Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases

Klick Health launches new healthcare venture studio

Medtech earnings reports: insights from major players' Q4 results

Key compliance issues for medtech firms transitioning to data-enabled solutions

Following FDA COVID vaccine advisory panel vote, Novavax is prepared to provide a revised vaccine

First-of-its-kind Whole Lung Simulator is Helping Michigan Researchers Predict New Treatments and Vaccines for TB – A Reemerging Global Health Threat

Novartis signs agreement with UN-backed Medicines Patent Pool to license generics of its CML drug

Korean firm LG Chem buying AVEO Oncology for $566M

Latest Pharmagather Articles

Behind the GoodRx-Express Scripts Partnership: How PBMs Profit from Discount Cards in Pharmacy Benefits (rerun)

Drug Channels

Winning the Race for Patient Access: Identifying Copay Accumulator Impact

Drug Channels

Gene Drives Are Coming

In the Pipeline

Organizing Our Thoughts About Cells - Finally

In the Pipeline

Drug Channels News Roundup, March 2023: My $0.02 on Insulin Price Cuts, AbbVie vs. AFPs, Optum Expands, ASAP340B, and Hooray for Pharmacists

Drug Channels

The Right Assay With the Right Cells

In the Pipeline

Informa Connect’s Annual Life Sciences Commercial Contracts & Chargebacks Congress

Drug Channels

Peptide-Encoded Screening Libraries

In the Pipeline

It's Not All Bad News: Data Shows There's a Collaborative Future for 340B

Drug Channels